Chronic Kidney Disease

Vadadustat demonstrated the efficacy and cardiovascular safety for the treatment of anemia in adult patients with dialysis-dependent chronic kidney disease, according to recently presented data.

The American Kidney Fund has partnered with Backpack Health, of Konica Minolta, to grant patients access to their medical records through the latter’s mobile- and web-based service.

Data included in a meta-analysis published in the Journal of Renal Nutrition show drinking coffee was associated with lower risks for incident chronic kidney disease, end-stage kidney disease, albuminuria and related mortality.

In a study of 63 patients with nondialysis-dependent chronic kidney disease stages 3 to 5, investigators found nutrient intake did not conform to dietary requirements, even when patients were aware of recommended nutrient volume limits.

Through Fresenius Medical Care North America’s recently announced partnership with Livongo Health Inc., patients will now be managed utilizing Livongo’s Whole Person for CKD virtual care-coordination services.

According to the latest U.S. Renal Data System report, Black individuals are three times and Hispanic individuals are 1.8 times more likely to require renal replacement therapy vs. white patients.

Dr. Francis Wels Peabody, MD, once wrote “The secret of the care of the patient is caring for the patient.”

Patients with a history of chronic kidney diseases who undergo Mohs surgery had a greater risk for postoperative complications, according to findings presented at the American Society for Dermatologic Surgery annual meeting.

Participants who engaged in more frequent physical activities had a lower risk for chronic kidney disease compared with participants who were inactive, according to a study published in American Journal of Kidney Diseases.

The FDA granted breakthrough therapy designation to the SGLT2 inhibitor dapagliflozin for adults with chronic kidney disease with and without type 2 diabetes, according to an industry press release.